Published in Surgery on October 01, 2002
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. J Clin Oncol (2015) 1.87
ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford) (2009) 1.44
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer (2006) 1.35
Transarterial chemoembolization (TACE) with mitomycin C and gemcitabine for liver metastases in breast cancer. Eur Radiol (2009) 1.21
Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. Cancer (2009) 1.14
A new clinically based staging system for perihilar cholangiocarcinoma. Am J Gastroenterol (2014) 1.10
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther (2011) 1.06
Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients. World J Surg (2012) 1.04
Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford) (2010) 0.97
Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 0.96
Metastatic lymph nodes in hilar cholangiocarcinoma: does size matter? HPB (Oxford) (2011) 0.95
Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92
Gallbladder cancer: what is an aggressive approach? Ann Surg (2005) 0.91
Radiation therapy, chemotherapy and chemoradiation in hilar cholangiocarcinoma. HPB (Oxford) (2005) 0.89
Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88
Concomitant dysregulation of microRNAs miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB (Oxford) (2012) 0.87
Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig Dis Sci (2007) 0.87
Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection. BMC Cancer (2011) 0.85
Evidence-based decompression in malignant biliary obstruction. Korean J Radiol (2012) 0.83
Adjuvant treatment in biliary tract cancer: to treat or not to treat? World J Gastroenterol (2012) 0.83
In-hospital mortality after resection of biliary tract cancer in the United States. HPB (Oxford) (2010) 0.80
Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol (2008) 0.79
Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study. Cancer Med (2017) 0.77
Early bile duct cancer. World J Gastroenterol (2007) 0.77
Chemotherapy and targeted therapy for gall bladder cancer. Indian J Surg Oncol (2014) 0.77
Clinical features and survival outcome of locally advanced extrahepatic cholangiocarcinoma. Korean J Hepatobiliary Pancreat Surg (2014) 0.75
The safety and efficacy of nasobiliary drainage versus biliary stenting in malignant biliary obstruction: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.75
Reduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells. Oncol Lett (2017) 0.75
Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther (2017) 0.75
Conditional probability of long-term survival after resection of hilar cholangiocarcinoma. HPB (Oxford) (2016) 0.75
Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence. Radiat Oncol J (2016) 0.75
Is an aggressive surgical approach worthwhile in biliary cancer? Int Semin Surg Oncol (2007) 0.75
Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis. PLoS One (2016) 0.75
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol (2006) 7.40
Cystic pancreatic neoplasms: observe or operate. Ann Surg (2004) 3.68
Bayesian population decoding of motor cortical activity using a Kalman filter. Neural Comput (2006) 3.63
Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg (2007) 3.38
Neural control of computer cursor velocity by decoding motor cortical spiking activity in humans with tetraplegia. J Neural Eng (2008) 3.18
Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol (2006) 2.70
Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery (2009) 2.64
Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg (2005) 2.58
Decoding complete reach and grasp actions from local primary motor cortex populations. J Neurosci (2010) 2.40
Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res (2003) 2.28
Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann Surg (2005) 2.27
TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 2.23
Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg (2007) 2.10
Point-and-click cursor control with an intracortical neural interface system by humans with tetraplegia. IEEE Trans Neural Syst Rehabil Eng (2011) 2.00
Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys (2010) 1.97
Research reporting standards for radioembolization of hepatic malignancies. J Vasc Interv Radiol (2011) 1.89
TG13 diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.84
TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.82
Addressing overutilization in medical imaging. Radiology (2010) 1.79
Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg (2010) 1.72
TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66
Background: Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Surg (2007) 1.64
Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg (2007) 1.62
Pancreatectomy risk calculator: an ACS-NSQIP resource. HPB (Oxford) (2010) 1.61
Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach. Surgery (2008) 1.58
Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.58
Annular pancreas in adults. AJR Am J Roentgenol (2009) 1.57
Influence of sleep stages on esophago-upper esophageal sphincter contractile reflex and secondary esophageal peristalsis. Gastroenterology (2006) 1.54
Modeling and decoding motor cortical activity using a switching Kalman filter. IEEE Trans Biomed Eng (2004) 1.53
TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.53
Fully covered self-expandable metal stents (SEMS), partially covered SEMS and self-expandable plastic stents for the treatment of benign esophageal ruptures and anastomotic leaks. BMC Gastroenterol (2012) 1.50
New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.49
Surgical treatment of patients with acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.49
Genomic signatures of cancer: basis for individualized risk assessment, selective staging and therapy. J Surg Oncol (2011) 1.48
Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A (2011) 1.47
Robotic distal pancreatectomy: cost effective? Surgery (2010) 1.47
Nonalcoholic fatty pancreas disease. HPB (Oxford) (2007) 1.44
Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg (2014) 1.44
Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.43
A nonparametric Bayesian alternative to spike sorting. J Neurosci Methods (2008) 1.41
Surgical treatment of choledochal cysts. J Hepatobiliary Pancreat Surg (2003) 1.40
TG13 surgical management of acute cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.39
Cystic pancreatic neoplasms: enucleate or resect? J Gastrointest Surg (2003) 1.37
On the variability of manual spike sorting. IEEE Trans Biomed Eng (2004) 1.36
CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg (2007) 1.34
Results of the Tokyo Consensus Meeting Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.32
Gallstones: genetics versus environment. Ann Surg (2002) 1.32
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg (2009) 1.29
Principles of training in GI endoscopy. Gastrointest Endosc (2011) 1.25
New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci (2012) 1.23
Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing. PLoS One (2012) 1.21
Annular pancreas: dramatic differences between children and adults. J Am Coll Surg (2008) 1.21
Colonoscopy core curriculum. Gastrointest Endosc (2012) 1.20
Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer. Mol Cancer Ther (2010) 1.20
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19
Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? J Gastrointest Surg (2002) 1.19
Methods and timing of biliary drainage for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.19
Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg (2009) 1.18
Adrenocortical cancer. Surg Clin North Am (2009) 1.17
Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2007) 1.16
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 1.16
Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg (2012) 1.16
Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointest Endosc (2010) 1.15
Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. Int J Radiat Oncol Biol Phys (2007) 1.15
A murine model of obesity implicates the adipokine milieu in the pathogenesis of severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol (2008) 1.14
Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2011) 1.13
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairs. BMC Genomics (2013) 1.13
Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol (2006) 1.13
Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg (2002) 1.13
Improved outcomes in postoperative and pancreatitis-related visceral pseudoaneurysms. J Gastrointest Surg (2007) 1.13
Analysis of the plasma peptidome from pancreas cancer patients connects a peptide in plasma to overexpression of the parent protein in tumors. J Proteome Res (2009) 1.12
Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surgery (2004) 1.10
Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer. Mol Cancer Ther (2008) 1.10
Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg (2009) 1.10
TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.09
Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Cancer Res (2013) 1.08
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc (2003) 1.07
Surgical management of pancreatic cancer. Oncology (Williston Park) (2002) 1.05
Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer. Clin Cancer Res (2003) 1.05
Declining morbidity and mortality rates in the surgical management of pancreatic necrosis. J Gastrointest Surg (2007) 1.04
Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford) (2010) 1.04
Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study. Surgery (2012) 1.03
Factors associated with delayed gastric emptying after pancreaticoduodenectomy. HPB (Oxford) (2013) 1.02
Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy. Ann Surg Oncol (2010) 1.02
Hepatic neuroendocrine metastases: chemo- or bland embolization? J Gastrointest Surg (2008) 1.02
Insulin resistance causes human gallbladder dysmotility. J Gastrointest Surg (2006) 1.00